Unique antibodies and patented antibody-based diagnostic products
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
115
NCT03333733
Protocol Feasibility Study of HENRY
Phase: N/A
Role: Collaborator
Start: Jul 30, 2017
Completion: Nov 8, 2019
Loading map...